A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
出版年份 2018 全文链接
标题
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
作者
关键词
Hypoxia, Cisplatin, Temozolomide, Chemoresistance, CD133, HIFs
出版物
CELLULAR ONCOLOGY
Volume 41, Issue 3, Pages 319-328
出版商
Springer Nature
发表日期
2018-02-28
DOI
10.1007/s13402-018-0374-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- (2017) Souvick Roy et al. CELLULAR ONCOLOGY
- Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition
- (2017) Diana Matias et al. CELLULAR ONCOLOGY
- Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways
- (2016) C. Petit et al. BMC CANCER
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- BIRC3 is a novel driver of therapeutic resistance in Glioblastoma
- (2016) Dapeng Wang et al. Scientific Reports
- Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome
- (2015) Arash Hamidian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 3D Porous Chitosan–Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer
- (2015) Kui Wang et al. BIOMACROMOLECULES
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation
- (2014) Laia Capdevila et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of hypoxia on human cancer cell line chemosensitivity
- (2013) Sara Strese et al. BMC CANCER
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype
- (2013) Shaun D. Fouse et al. NEURO-ONCOLOGY
- Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
- (2013) Jennifer Adamski et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
- (2013) Marju Kase et al. Radiology and Oncology
- CD133 Is Essential for Glioblastoma Stem Cell Maintenance
- (2013) Paola Brescia et al. STEM CELLS
- What makes cancer stem cell markers different?
- (2013) Uwe Karsten et al. SpringerPlus
- Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
- (2012) Liuqi Yang et al. EXPERIMENTAL CELL RESEARCH
- The cellular origin for malignant glioma and prospects for clinical advancements
- (2012) Hui Zong et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
- (2012) Chii-Wen Chou et al. NEURO-ONCOLOGY
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner
- (2011) Rui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High drug attrition rates—where are we going wrong?
- (2011) Lisa Hutchinson et al. Nature Reviews Clinical Oncology
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells
- (2010) Lin Dong et al. NEUROSCIENCE LETTERS
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
- (2008) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started